Sung Lee, Executive Vice President, Chief Financial Officer, on June 29, 2026, sold 3,134 shares in Cytokinetics (CYTK) for $266,390. Following the Form 4 filing with the SEC, Lee has control over a total of 63,221 common shares of the company, with 63,221 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1061983/000106198326000070/xslF345X05/form4.xml